Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12
| Status: | Recruiting |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 4/2/2016 |
| Start Date: | February 2014 |
| End Date: | November 2018 |
| Contact: | Kayvan Taghipour-Khiabani, M.D. |
| Email: | kkhiabani@medicine.nevada.edu |
| Phone: | 702-671-2267 |
Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12
The purpose of this study is to measure the level of AlloMax™ incorporation (cellular
infiltration, collagen production, and neovascularization) in human breast reconstruction.
The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast
capsule at the 3-4 month time point.
infiltration, collagen production, and neovascularization) in human breast reconstruction.
The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast
capsule at the 3-4 month time point.
Inclusion Criteria:
- Adult patients (18 - 70 yrs) who require reconstructive breast surgery with AlloMaxTM
implants and agree to participate will be included in this study.
Exclusion Criteria:
- Patients who do not agree to be included in the study.
We found this trial at
1
site
Click here to add this to my saved trials
